Email Alert RSS
Volume 11 Issue 2
Mar.  2020
Turn off MathJax
Article Contents
Abstract
References
Reziya ABUDUXUKUER, Shan LYU, Yao-de HE, Hang JIN, Zhen-ni GUO, Yi YANG. Rearch Course of Reperfusion Therapy for Acute Ischemic Stroke[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(2): 162-169. DOI: 10.3969/j.issn.1674-9081.20190273
Citation: Reziya ABUDUXUKUER, Shan LYU, Yao-de HE, Hang JIN, Zhen-ni GUO, Yi YANG. Rearch Course of Reperfusion Therapy for Acute Ischemic Stroke[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(2): 162-169. DOI: 10.3969/j.issn.1674-9081.20190273
shu

Rearch Course of Reperfusion Therapy for Acute Ischemic Stroke

  • Department of Neurology, The First Hospital of Jilin University, Changchun 130021, China

More Information
  • Corresponding author:

    YANG Yi Tel: 86-431-88782378, E-mail:doctoryangyi@163.com

  • Received Date: December 08, 2019
  • Issue Publish Date: March 29, 2020
    Graphical Abstract
    • Abstract
  • Acute ischemic stroke(AIS), characterized by its high morbidity, high mortality, and high disability, is the most common subtype of stroke. Rapidly recanalizing the occluded arteries to salvage ischemic parenchyma in the early stage is essential to treat AIS, which mainly includes intravenous thrombolysis and endovascular treatment. The reperfusion therapy of AIS has been studied for over thirty years developing from intravenous thrombolysis(IVT) to endovascular treatment. There are three main stages in the evolution of reperfusion therapy:(1)investigating thrombolytic agents, which commenced the era of IVT in treating AIS; (2)investigating the dose and time window of thrombolytic agents to maximize the benefit and minimize the risk of IVT; (3)investigating mechanical thrombectomy for AIS, which contributes to the diversification and individualization of reperfusion therapy. Currently, IVT, bridging therapy, and direct mechanical thrombectomy can be applied to treating AIS according to the duration from the onset, the severity of clinical manifestation, and findings in the imaging examination.
    • FullText(HTML)
    • References (74)
  • [1]
    Wang W, Jiang B, Sun H, et al. Prevalence, Incidence, and Mortality of Stroke in China:Results from a Nationwide Population-Based Survey of 480687 Adults[J]. Circulation, 2017, 135:759-771. http://svn.bmj.com/lookup/ijlink?linkType=ABST&journalCode=circulationaha&resid=135/8/759&atom=%2Fsvnbmj%2F2%2F3%2F132.atom
    [2]
    中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志, 2018, 51:666-682. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhsjk201809005
    [3]
    Sussman BJ, Fitch TS. Thrombolysis with fibrinolysin in cerebral arterial occlusion[J]. J Am Med Assoc, 1958, 167:1705-1709. http://onlinelibrary.wiley.com/resolve/reference/PMED?id=13563167
    [4]
    张和.卒中治疗——Zivin与阿替普酶[J].中国卒中杂志, 2017, 12:727-728. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgzzzz201708015
    [5]
    Zivin JA, Fisher M, Degirolami U, et al. Tissue plasm-inogen activator reduces neurological damage after cerebral embolism[J]. Science, 1985, 230:1289-1292. http://www.ncbi.nlm.nih.gov/pubmed/3934754
    [6]
    National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med, 1995, 333:1581-1587.
    [7]
    Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for Thrombolytic Therapy for Acute Stroke:a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association[J]. Circulation, 1996, 94:1167-1174. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1177/0148607102026001011
    [8]
    Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study(ECASS)[J]. JAMA, 1995, 274:1017-1025. http://pmj.bmj.com/external-ref?access_num=10.1001/jama.1995.03530130023023&link_type=DOI
    [9]
    Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke(ECASS Ⅱ). Second European-Australasian Acute Stroke Study Investigators[J]. Lancet, 1998, 352:1245-1251. http://www.europepmc.org/abstract/MED/9788453
    [10]
    Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator(Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study:a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke[J]. JAMA, 1999, 282:2019-2026. http://www.tandfonline.com/servlet/linkout?suffix=CIT0028&dbid=16&doi=10.1517%2F14656560802521650&key=10.1001%2Fjama.282.21.2019
    [11]
    Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA(alteplase) 0- to 6-hour acute stroke trial, part A(A0276g):results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators[J]. Stroke, 2000, 31:811-816. http://bja.oxfordjournals.org/cgi/ijlink?linkType=ABST&journalCode=strokeaha&resid=31/4/811
    [12]
    Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment:pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials[J]. Lancet, 2004, 363:768-774. http://www.ncbi.nlm.nih.gov/pubmed/15016487
    [13]
    卢海涛, 张小年, 周维金.缺血性脑卒中患者的早期处理指南(四)[J].中国康复理论与实践, 2004, 10:121-125. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgkfllysj200402029
    [14]
    Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med, 2008, 359:1317-1329. DOI: 10.1007/s00390-008-0018-8
    [15]
    Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial(EPITHET):a placebo-controlled randomised trial[J]. Lancet Neurol, 2008, 7:299-309. http://brain.oxfordjournals.org/lookup/external-ref?access_num=18296121&link_type=MED&atom=%2Fbrain%2Fearly%2F2015%2F03%2F23%2Fbrain.awv071.atom
    [16]
    Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials[J]. Lancet, 2010, 375:1695-1703.
    [17]
    中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国全科医学, 2011, 14:4013-4017. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgqkyx201135004
    [18]
    金征宇, 孙昊.新时代放射影像临床诊疗路径的思考[J].协和医学杂志, 2019, 10:2-5. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xhyx201901002
    [19]
    Thomalla G, Rossbach P, Rosenkranz M, et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less[J]. Ann Neurol, 2009, 65:724-732. DOI: 10.1002/ana.21651/full
    [20]
    Thomalla G, Fiebach JB, Østergaard L, et al. A multi-center, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke(WAKE-UP)[J]. Int J Stroke, 2014, 9:829-836. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=WK_MED201810241505
    [21]
    Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset[J].N Engl J Med, 2018, 379:611-622. http://www.ncbi.nlm.nih.gov/pubmed/29766770
    [22]
    Amiri H, Bluhmki E, Bendszus M, et al. European Cooperative Acute Stroke Study-4:Extending the time for thrombolysis in emergency neurological deficits ECASS-4:ExTEND[J]. Int J Stroke, 2016, 11:260-267. DOI: 10.1177/1747493015620805
    [23]
    Ma H, Parsons MW, Christensen S, et al. A multicentre, randomized, double-blinded, placebo-controlled Phase Ⅲ study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits(EXTEND)[J]. Int J Stroke, 2012, 7:74-80.
    [24]
    Campbell BCV, Ma H, Ringleb PA, et al. Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging:a systematic review and meta-analysis of individual patient data[J]. Lancet, 2019, 394:139-147. http://www.sciencedirect.com/science/article/pii/S0140673619310530
    [25]
    Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke:2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J]. Stroke, 2019, 50:e344-e418.
    [26]
    Huang Y, Sharma VK, Robinson T, et al. Rationale, design, and progress of the ENhanced Control of Hyperten-sion ANd Thrombolysis strokE stuDy(ENCHANTED) trial:An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment[J]. Int J Stroke, 2015, 10:778-788. DOI: 10.1111/ijs.12486
    [27]
    Coutts SB, Berge E, Campbell BC, et al. Tenecteplase for the treatment of acute ischemic stroke:A review of completed and ongoing randomized controlled trials[J]. Int J Stroke, 2018, 13:885-892. DOI: 10.1177/1747493018790024
    [28]
    Bivard A, Huang X, McElduff P, et al. Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke:Analysis of 2 Randomized Controlled Trials[J]. Circulation, 2017, 135:440-448. DOI: 10.1161/CIRCULATIONAHA.116.022582
    [29]
    Campbell BC, Mitchell PJ, Churilov L, et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke[J]. N Engl J Med, 2018, 378:1573-1582. DOI: 10.1056/NEJMoa1716405
    [30]
    Campbell BC, Mitchell PJ, Churilov L, et al. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke(EXTEND-IA TNK Part 2):A multicenter, randomized, controlled study[J]. Int J Stroke, 2019. doi: 10.1177/1747493019879652.[Epub ahead of print].
    [31]
    Fletcher AP, Alkjaersig N, Lewis M, et al. A pilot study of urokinase therapy in cerebral infarction[J]. Stroke, 1976, 7:135-142. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=WK_LWW2017052520654873
    [32]
    饶明俐, 张秉枢, 常庆有.尿激酶治疗脑血管关闭30例临床分析[J].白求恩医科大学学报, 1978, (04):48-53. http://search.cnki.net/down/default.aspx?filename=BQEB197804007&dbcode=CJFD&year=1978&dflag=pdfdown
    [33]
    国家"九五"公关课题协作组.急性脑梗死(6 h以内)静脉溶栓治疗[J].中风与神经疾病杂志, 2004, 18:259-261. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zfysjjbzz200105001
    [34]
    国家"九五"公关课题协作组.急性脑梗死六小时以内的静脉溶栓治疗[J].中华神经科杂志, 2002, 35:210-213. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhsjk200204007
    [35]
    Wang Y, Liao X, Zhao X, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China:analysis of the results from the Chinese National Stroke Registry(CNSR)[J]. Stroke, 2011, 42:1658-1664. DOI: 10.1161/STROKEAHA.110.604249
    [36]
    Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study(SITS-MOST):an observational study[J]. Lancet, 2007, 369:275-282. DOI: 10.1016/S0140-6736(07)60149-4
    [37]
    Leys D, Cordonnier C, Debette S, et al. Facilities available in French hospitals treating acute stroke patients:comparison with 24 other European countries[J]. J Neurol, 2009, 256:867-873. DOI: 10.1007/s00415-009-5029-2
    [38]
    Del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT:a phase Ⅱ randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism[J]. Stroke, 1998, 29:4-11. DOI: 10.1161/01.STR.29.1.4
    [39]
    Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT Ⅱ study:a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism[J]. JAMA, 1999, 282:2003-2011. DOI: 10.1001/jama.282.21.2003
    [40]
    Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke:Emergency Management of Stroke(EMS) Bridging Trial[J]. Stroke, 1999, 30:2598-2605. DOI: 10.1161/01.STR.30.12.2598
    [41]
    Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1:a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia[J]. Stroke, 2004, 35:2848-2854. DOI: 10.1161/01.STR.0000147718.12954.60
    [42]
    中华医学会神经病学分会, 中华医学会神经病学分会神经血管介入协作组, 急性缺血性脑卒中介入诊疗指南撰写组.中国急性缺血性脑卒中早期血管内介入诊疗指南[J].中华神经科杂志, 2015, 48:356-361. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhsjk201505002
    [43]
    IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke:the Interventional Management of Stroke Study[J]. Stroke, 2004, 35:904-911. DOI: 10.1161/01.STR.0000121641.77121.98
    [44]
    IMS Ⅱ Trial Investigators. The Interventional Management of Stroke(IMS) Ⅱ Study[J]. Stroke, 2007, 38:2127-2135. DOI: 10.1161/STROKEAHA.107.483131
    [45]
    Smith WS. Safety of mechanical thrombectomy and intraven-ous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia(MERCI) trial, part I[J]. AJNR Am J Neuroradiol, 2006, 27:1177-1182.
    [46]
    Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke:the middle cerebral artery embolism local fibrinolytic intervention trial(MELT) Japan[J]. Stroke, 2007, 38:2633-2639. DOI: 10.1161/STROKEAHA.107.488551
    [47]
    Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke[J]. N Engl J Med, 2013, 368:893-903. DOI: 10.1056/NEJMoa1214300
    [48]
    Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke[J]. N Engl J Med, 2013, 368:904-913. DOI: 10.1056/NEJMoa1213701
    [49]
    Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke[J]. N Engl J Med, 2013, 368:914-923. DOI: 10.1056/NEJMoa1212793
    [50]
    Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke(SWIFT):a randomised, parallel-group, non-inferiority trial[J]. Lancet, 2012, 380:1241-1249. DOI: 10.1016/S0140-6736(12)61384-1
    [51]
    Nogueira RG, Lutsep HL, Gupta R, et al. TREVO versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke(TREVO 2):a randomised trial[J]. Lancet, 2012, 380:1231-1240. DOI: 10.1016/S0140-6736(12)61299-9
    [52]
    Berkhemer OA, Fransen PS, Beumer D, et al. A rando-mized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med, 2015, 372:11-20. DOI: 10.1056/NEJMoa1411587
    [53]
    Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med, 2015, 372:1019-1030. DOI: 10.1056/NEJMoa1414905
    [54]
    Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med, 2015, 372:1009-1018. DOI: 10.1056/NEJMoa1414792
    [55]
    Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med, 2015, 372:2285-2295. DOI: 10.1056/NEJMoa1415061
    [56]
    Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med, 2015, 372:2296-2306. DOI: 10.1056/NEJMoa1503780
    [57]
    Badhiwala JH, Nassiri F, Alhazzani Waleed, et al. Endovascular Thrombectomy for Acute Ischemic Stroke:A Meta-analysis[J]. JAMA, 2015, 314:1832-1843. DOI: 10.1001/jama.2015.13767
    [58]
    Bracard S, Ducrocq X, Mas JL, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke(THRACE):a randomised controlled trial[J]. Lancet Neurol, 2016, 15:1138-1147. DOI: 10.1016/S1474-4422(16)30177-6
    [59]
    Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46:3020-3035. DOI: 10.1161/STR.0000000000000074
    [60]
    Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct[J]. N Engl J Med, 2018, 378:11-21. DOI: 10.1056/NEJMoa1706442
    [61]
    Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging[J]. N Engl J Med, 2018, 378:708-718. DOI: 10.1056/NEJMoa1713973
    [62]
    中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组, 中华医学会神经病学分会神经血管介入协作组.中国急性缺血性脑卒中早期血管内介入诊疗指南2018[J].中华神经科杂志, 2018, 51:683-691. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhsjk201809006
    [63]
    Liu X, Dai Q, Ye R, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion(BEST):an open-label, randomised controlled trial[J]. Lancet Neurol, 2020, 19:115-122. DOI: 10.1016/S1474-4422(19)30395-3
    [64]
    Toni D, Mangiafico S, Agostoni E, et al. Intravenous thrombolysis and intra-arterial interventions in acute ischemic stroke:Italian Stroke Organisation(ISO)-SPREAD guidelines[J]. Int J Stroke, 2015, 10:1119-1129. DOI: 10.1111/ijs.12604
    [65]
    Wahlgren N, Moreira T, Michel P, et al. Mechanical thrombectomy in acute ischemic stroke:Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN[J]. Int J Stroke, 2016, 11:134-147. DOI: 10.1177/1747493015609778
    [66]
    Coutinho JM, Liebeskind DS, Slater LA, et al. Combined Intravenous Thrombolysis and Thrombectomy vs Thrombecto-my Alone for Acute Ischemic Stroke:A Pooled Analysis of the SWIFT and STAR Studies[J]. JAMA Neurol, 2017, 74:268-274. DOI: 10.1001/jamaneurol.2016.5374
    [67]
    Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke[J]. Stroke, 2007, 38:948-954. DOI: 10.1161/01.STR.0000257304.21967.ba
    [68]
    Guedin P, Larcher A, Decroix JP, et al. Prior IV Thrombolysis Facilitates Mechanical Thrombectomy in Acute Ischemic Stroke[J]. J Stroke Cerebrovasc Dis, 2015, 24:952-957. DOI: 10.1016/j.jstrokecerebrovasdis.2014.12.015
    [69]
    Behme D, Kabbasch C, Kowoll A, et al. Intravenous Thrombolysis Facilitates Successful Recanalization with Stent-Retriever Mechanical Thrombectomy in Middle Cerebral Artery Occlusions[J]. J Stroke Cerebrovasc Dis, 2016, 25:954-959. DOI: 10.1016/j.jstrokecerebrovasdis.2016.01.007
    [70]
    Kaesmacher J, Kleine JF. Bridging Therapy with i.v. rtPA in MCA Occlusion Prior to Endovascular Thrombectomy:a Double-Edged Sword?[J]. Clin Neuroradiol, 2018, 28:81-89. DOI: 10.1007/s00062-016-0533-0
    [71]
    Almekhlafi MA, Hill MD, Roos YM, et al. Stroke Laterality Did Not Modify Outcomes in the HERMES Meta-Analysis of Individual Patient Data of 7 Trials[J]. Stroke, 2019, 50:2118-2124. DOI: 10.1161/STROKEAHA.118.023102
    [72]
    Saver JL, Goyal M, van der Lugt A, et al. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke:A Meta-analysis[J]. JAMA, 2016, 316:1279-1288. DOI: 10.1001/jama.2016.13647
    [73]
    Wang H, Zi W, Hao Y, et al. Direct endovascular treatment:an alternative for bridging therapy in anterior circulation large-vessel occlusion stroke[J]. Eur J Neurol, 2017, 24:935-943. DOI: 10.1111/ene.13311
    [74]
    Liu M, Li G. Is Direct Endovascular Treatment as an Alternative of Bridging Therapy in Acute Stroke Patients with Large Vessel Occlusion?[J]. J Stroke Cerebrovasc Dis, 2019, 28:531-541. DOI: 10.1016/j.jstrokecerebrovasdis.2018.10.007
    • Related Articles

  • Cited by

    Periodical cited type(1)

    1. 张璨，张雨寒，潘俣彤，鲁利群. 我国现代儿科学教育的发展回顾与展望. 中华医学教育探索杂志. 2024(06): 742-747 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (711) PDF downloads (172) Cited by(1)
    Related
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

      Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return
      x Close Forever Close